MedTrace Logo

Prevalence of Neuropsychiatric Manifestations in IBD Patients in Upper Egypt

NCT04573400 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-10-05

No results posted yet for this study

Summary

Estimation of neuropsychiatric symptoms prevalence in IBD patients and their impact on quality of life.

Conditions

Interventions

OTHER

HADS

The HADS is a 14-item self-report questionnaire assessing levels of anxiety (seven items) and depression (seven items) over the past week. Each question is assessed on a 4-point Likert Scale: "I feel tense or 'wound up'" (0= not at all 3= most of the time). Consistent with recommendations by Bjelland et al cut-off of 8 for each HADS subscale will be used to differentiate normal from mild to severe distress.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2022-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573400 on ClinicalTrials.gov